Download presentation
Presentation is loading. Please wait.
Published byPiers Garrett Modified over 6 years ago
1
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer Katsutoshi Enokido, Chie Watanabe, Seigo Nakamura, Akiko Ogiya, Tomo Osako, Futoshi Akiyama, Akiyo Yoshimura, Hiroji Iwata, Shinji Ohno, Yasuyuki Kojima, Koichiro Tsugawa, Kazuyoshi Motomura, Naoki Hayashi, Hideko Yamauchi, Nobuaki Sato Clinical Breast Cancer Volume 16, Issue 4, Pages (August 2016) DOI: /j.clbc Copyright © 2016 The Authors Terms and Conditions
2
Figure 1 Tumor Identification Rate According to Clinical Tumor Biomarkers Abbreviations: ER = estrogen receptor; HER2 = human epithelial growth factor 2; TNBC = triple-negative breast cancer. Clinical Breast Cancer , DOI: ( /j.clbc ) Copyright © 2016 The Authors Terms and Conditions
3
Figure 2 False-Negative Rate According to Clinical Tumor Biomarkers
Abbreviations: ER = estrogen receptor; HER2 = human epithelial growth factor 2; TNBC = triple-negative breast cancer. Clinical Breast Cancer , DOI: ( /j.clbc ) Copyright © 2016 The Authors Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.